Milestone Scientific Inc. (MLSS)

Market Cap	64.21M
Revenue (ttm)	9.41M
Net Income (ttm)	-7.85M
Shares Out	69.80M
EPS (ttm)	-0.12
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	57,322
Open	0.910
Previous Close	0.912
Day's Range	0.890 - 0.920
52-Week Range	0.410 - 1.600
Beta	1.41
Analysts	Buy
Price Target	4.08 (+343.48%)
Earnings Date	May 15, 2023

About MLSS

Milestone Scientific Inc. designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. The company also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Nov 3, 1995
• Employees: 26
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: MLSS

Financial Performance

In 2021, MLSS's revenue was $10.30 million, an increase of 89.52% compared to the previous year's $5.44 million. Losses were -$6.82 million, -7.07% less than in 2020.

Analyst Forecast

According to 7 analysts, the average rating for MLSS stock is "Buy." The 12-month stock price forecast is $4.08, which is an increase of 343.48% from the latest price.

Price Target

$4.08

(343.48% upside)

Analyst Consensus: Buy